Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017

Details for Mechanism ID: 18167
Country/Region: India
Year: 2017
Main Partner: University of Washington
Main Partner Program: NA
Organizational Type: University
Funding Agency: HHS/HRSA
Total Funding: $600,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $85,000
Treatment: Adult Treatment (HTXS) $485,000
Treatment: Pediatric Treatment (PDTX) $30,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
TX_CURR Aggregated Age/Sex: <15 Female 2018 2,881
TX_CURR Aggregated Age/Sex: <15 Male 2018 3,539
TX_CURR Aggregated Age/Sex: 15+ Female 2018 68,486
TX_CURR Aggregated Age/Sex: 15+ Male 2018 71,937
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 146,843
TX_CURR Sum of Aggregated Age/Sex <15 2018 6,420
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 140,423
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 146,843
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 250
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 360
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 9,931
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 10,934
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 21,475
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 21,475
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 73,426
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 58,741
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,156
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,415
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 27,397
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 28,773
TX_PVLS Numerator: Indication: Routine 2018 58,741
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,444
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,773
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 34,243
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 35,966
TX_PVLS_den Denominator: Indication: Routine 2018 73,426
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 243
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 343
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 9,609
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 10,579
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 20,774
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 25,961
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 304
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 430
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 12,012
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 13,215